We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including comple... read more Featured Products: More products

Download Mobile App




Multiplex Molecular Assay Identifies Major Vaginal Lactobacilli

By LabMedica International staff writers
Posted on 26 Mar 2014
Lactobacilli play a key role in promoting vaginal health and depletion of these bacteria is associated with bacterial vaginosis (BV), the most common vaginal disorder.

A novel single-tube multiplex quantitative polymerase chain reaction (qPCR) assay for the identification and quantitative assessment of the four major vaginal Lactobacillus species has been developed. More...


Microbiologists at the Femeris Women's Health Research Center (Hamilton, NJ, USA) assessed 60 vaginal swab specimens as part of a study on BV pathogenesis. Samples were shipped frozen in Universal Transport Medium (UTM-RT) (Copan Italia SpA; Brescia, Italy) from August to October of 2012.

DNA from clinical samples was extracted using the QIAamp Mini Kit (Qiagen; Valencia, CA, USA) in combination with pretreatment with proteinase K and mechanical homogenization. Multiplex and uniplex TaqMan qPCRs were performed using primers and probes from Integrated DNA Technologies (Coralville, IA, USA) and Qiagen’s RotorGene Q instruments were used for all qPCR assays.

The assay utility was evaluated by the analysis of lactobacilli in noncultured clinical vaginal swab specimens collected from BV patients and healthy individuals. As confirmed by the assay, L. crispatus, L. jensenii, and to a lesser extent L. gasseri, are common in the vagina of healthy women, whereas L. iners dominance is associated with BV. In order to confirm multiplex TaqMan qPCR results, bacterial cultures were isolated from vaginal samples and 11 swab specimens yielded isolates of Lactobacillus species identified in them by the multiplex TaqMan qPCR assay. A total of 11 individual Lactobacillus strains were obtained: three L. crispatus, two L. gasseri, two L. jensenii, and four L. iners. Their species assignments were confirmed by both multiplex TaqMan qPCR and uniplex SYBR Green qPCRs with 100% concordance.

The authors concludes that their assay had been validated using bacterial cultures of lactobacilli and other microbial commensal and pathogenic species populating the microflora of the lower female genital tract, human chromosomal DNA, synthetic plasmid controls, and clinical vaginal swab specimens. The multiplex qPCR assay is an advance in the detection and quantitation of the major vaginal lactobacilli, potentially facilitating the molecular diagnosis of BV and post-therapy restoration of the vaginal microflora. The study was published online on January 18, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Femeris Women's Health Research Center
Copan Italia 
Qiagen


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automatic Hematology Analyzer
LABAS F9000
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.